Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Intensification in HIV with Suboptimal CD4 Recovery
NCT02934022Completed
- Sponsor
- Southern California Institute for Research and Education
- Start
- Jun 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Southern California Institute for Research and Education. Primary endpoint: Change in absolute CD4 lymphocyte count at 12 months. Started Jun 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02934022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934022.